Researchers from seven institutions received an $8.6 million grant from the National Institutes of Health (NIH) to conduct research on the anatomy and function of the nerves that control the heart.

Abbott Laboratories announced that it plans on completing its acquisition of St. Jude Medical Jan. 4.

Abbott announced that the company’s board of directors increased its quarterly dividend by 0.5 cents to 26.5 cents per common share.

The Centers for Medicare & Medicaid Services (CMS) finalized three new payment models to improve cardiac care, reduce preventable readmissions and decrease costs.

The American Heart Association (AHA) released a policy statement urging the Centers for Medicare & Medicaid Services (CMS) to cover evidence-based telehealth interventions for all Medicare beneficiaries who suffer from cardiovascular disease and stroke.

Forest Laboratories and Forest Pharmaceuticals agreed to pay $38 million to the federal government and several states to settle allegations regarding sales and marketing practices involving three medications.

When it comes to generic heart failure treatments, patients may be surprised at the variation in prices even within the same zip code.

Sanofi plans on laying off 20 percent of the company’s diabetes and cardiovascular staff, the Boston Business Journal reports.